Systemic mastocytosis revisited with an emphasis on skeletal manifestations.
Bone marrow
CT
Magnetic resonance imaging
Radiography
Systemic mastocytosis
Journal
La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
26
07
2020
accepted:
15
11
2020
pubmed:
27
11
2020
medline:
14
4
2021
entrez:
26
11
2020
Statut:
ppublish
Résumé
Systemic mastocytosis (SM) is a rare form of mastocytosis that can affect various organ systems. Bone involvement is the most common and prominent imaging feature in patients with SM regardless of the subtype. Furthermore, bone involvement is a prognostic factor as it may entail an aggressive course of the disease. Diagnosis is established by bone marrow biopsy complemented by imaging modalities such as radiography, CT, and magnetic resonance (MR) imaging. The radiographic and CT appearances are that of sclerotic, lytic, or mixed patterns with focal or diffuse distribution, involving primarily the axial skeleton and the ends of the long bones. Bone marrow infiltration is best recognized on MR imaging. Osteoporosis is common in SM; thus, a bone mineral density measurement at lumbar spine and proximal femur by dual-energy X-ray absorptiometry should be obtained. Imaging plays a huge part in the diagnostic process; when skeletal imaging findings are carefully interpreted and correlated with clinical features, they can lead to the suspicion of SM. The primary aims of this review article were to focus on the role of imaging in detection and characterization of skeletal patterns of SM and to discuss relevant clinical features that could facilitate prompt and correct diagnosis.
Identifiants
pubmed: 33242205
doi: 10.1007/s11547-020-01306-8
pii: 10.1007/s11547-020-01306-8
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
585-598Références
Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD (1991) Demonstration of the origin of humanmast cells from CD34 + bone marrow progenitor cells. J Immunol 146:1410–1415
pubmed: 1704394
Krystel-Whittemore M, Dileepan KN, Wood JG (2016) Mast cell A. Multi-functional master cell. Front Immunol 6:620. https://doi.org/10.3389/fimmu.2015.00620
doi: 10.3389/fimmu.2015.00620
pubmed: 26779180
pmcid: 4701915
da Silva EZ, Jamur MC, Oliver C (2014) Mast cell function: a new vision of an old cell. J Histochem Cytochem 62(10):698–738
pubmed: 25062998
pmcid: 4230976
Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD (1999) Demonstration that human mast cells arise from a progenitor cell population that is CD34( + ), c-kit (+), and expresses aminopeptidase N (CD13). Blood 94(7):2333–2342
pubmed: 10498605
Horny HP, Metcalfe DD, Akin C et al (2017) Mastocytosis. In: Swerdlow SH et al (eds) WHO classification of tumors of hematopoietic and lymphoid tissues. International Agency for Research and Cancer , Lyon
Pardanani A (2019) Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol 94(3):363–377
pubmed: 30536695
Amagai Y, Tanaka A, Matsuda A, Jung K, Ohmori K, Matsuda H (2013) Stem cell factor contributes to tumorigenesis of mast cells via an autocrine/paracrine mechanism. J Leukoc Biol 93(2):245–250
pubmed: 23125456
Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405
pubmed: 27069254
Monnier J, Georgin-Lavialle S, Canioni D et al (2016) Mast cell sarcoma: new cases and literature review. Oncotarget 7(40):66299–66309
pubmed: 27602777
pmcid: 5323235
Pardanani A, Akin C, Valent P (2006) Pathogenesis, clinical features, and treatment advances in mastocytosis. Best Pract Res Clin Haematol 19:595–615
pubmed: 16781490
Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG (1988) Systemic mast cell disease. Analysis of 58 cases and literature review. Med (Baltim) 67:345–368
Akin C, Metcalfe DD (2004) Systemic mastocytosis. Annu Rev Med 55:419–432
pubmed: 14746529
Riffel P, Schwaab J, Lutz C et al (2020) An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis. J Cancer Res Clin Oncol 146(4):945–951
pubmed: 31980928
pmcid: 7085471
Barete S, Assous N, de Gennes C et al (2010) Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis 69(10):1838–1841
pubmed: 20570833
Johansson C, Roupe G, Lindstedt G, Mellström D (1996) Bone density, bone markers and bone radiological features in mastocytosis. Age Ageing 25(1):1–7
pubmed: 8670521
Ragipoglu D, Dudeck A, Haffner-Luntzer M et al (2020) The role of mast cells in bone metabolism and bone disorders. Front Immunol 11:163. https://doi.org/10.3389/fimmu.2020.00163
doi: 10.3389/fimmu.2020.00163
pubmed: 32117297
pmcid: 7025484
Chiappetta N, Gruber B (2006) The role of mast cells in osteoporosis. Semin Arthritis Rheum 36(1):32–36
pubmed: 16887466
McKenna MJ (1994) Histomorphometric study of mast cells in normal bone, osteoporosis and mastocytosis using a new stain. Calcif Tissue Int 55(4):257–259
pubmed: 7529657
Irie A, Takami M, Kubo H, Sekino-Suzuki N, Kasahara K, Sanai Y (2007) Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Bone 41:165–174
pubmed: 17560185
Theoharides TC, Boucher W, Spear K (2002) Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 128(4):344–350
pubmed: 12218373
Kinjo M, Setoguchi S, Solomon DH (2008) Anti-histamine therapy and bone mineral density: analysis in a population-based U.S. sample. Am J Med 121(12):1085–1091
pubmed: 19028205
pmcid: 2943241
Orsolini G, Viapiana O, Rossini M, Bonifacio M, Zanotti R (2018) Bone disease in mastocytosis. Immunol Allergy Clin North Am 38(3):443–454
pubmed: 30007462
Garla VV, Chaudhary KUQ, Yaqub A (2019) Systemic mastocytosis: a rare cause of osteoporosis. Pan Afr Med J 32:169. https://doi.org/10.11604/pamj.2019.32.169.16640
doi: 10.11604/pamj.2019.32.169.16640
pubmed: 31303938
pmcid: 6607299
Biosse-Duplan M, Baroukh B, Dy M, de Vernejoul MC, Saffar JL (2009) Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. Am J Pathol 174(4):1426–1434
pubmed: 19264900
pmcid: 2671373
de Gennes C, Kuntz D, de Vernejoul MC (1992) Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop Relat Res 279:281–291
Valent P, Akin C, Gleixner KV et al (2019) Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches. Int J Mol Sci 20(12):2976. https://doi.org/10.3390/ijms20122976
doi: 10.3390/ijms20122976
pmcid: 6627900
Lim KH, Tefferi A, Lasho TL et al (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113(23):5727–5736
pubmed: 19363219
Kurian CJ, Madhavan I, Krishnankutty PK, Andrews MA (2014) Compressive myelopathy caused by isolated epidural myeloid sarcoma with systemic mastocytosis. Rare presentation of a hematological malignancy. Neurosciences 19(3):238–239 (Riyadh)
pubmed: 24983289
Zafar A, Frygier A, Strickland S, Turney R, Spink G (2020) A rare case of spinal mastocytosis presenting as an extradural mass. World Neurosurg 133:17–20
pubmed: 31491575
Theoharides TC, Valent P, Akin C (2015) Mast cells, mastocytosis, and related disorders. N Engl J Med 373(19):1885–1886
pubmed: 26535528
Butterfield JH, Weiler CR (2013) Systemic mastocytosis in the elderly. Am J Hematol 88(5):406–408
pubmed: 23436294
Harzy T, El Hajjaji A (2007) Osseous mastocytosis of the knee. Clin Rheumatol 26(12):2171–2172
pubmed: 17549581
Delsignore JL, Dvoretsky PM, Hicks DG, O’Keefe RJ, Rosier RN (1996) Mastocytosis presenting as a skeletal disorder. Iowa Orthop J 16:126–134
pubmed: 2378151
pmcid: 2378151
Fritz J, Fishman EK, Carrino JA, Horger MS (2012) Advanced imaging of skeletal manifestations of systemic mastocytosis. Skeletal Radiol 41(8):887–897
pubmed: 22366736
Hwang S, Panicek DM (2007) Magnetic resonance imaging of bone marrow in oncology, part 2. Skeletal Radiol 36(11):1017–1027
pubmed: 17492444
Shah LM, Hanrahan CJ (2011) MRI of spinal bone marrow: part I, techniques and normal age-related appearances. AJR Am J Roentgenol 197(6):1298–1308
pubmed: 22109283
Benli IT, Akalin S, Boysan E et al (1992) Epidemiological, clinical and radiological aspects of osteopoikilosis. J Bone Jt Surg Br 74:504–506
Vanhoenacker FM, De Beuckeleer LH, Van Hul W et al (2000) Sclerosing bone dysplasias: genetic and radioclinical features. Eur Radiol 10(9):1423–1433
pubmed: 10997431
Ihde LL, Forrester DM, Gottsegen CJ et al (2011) Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis. Radiographics 31(7):1865–1882
pubmed: 22084176
Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report WHO Study Group. Osteoporos Int 4(6):368–381
pubmed: 7696835
Degboé Y, Eischen M, Nigon D et al (2017) Prevalence and risk factors for fragility fracture in systemic mastocytosis. Bone 105:219–225
pubmed: 28919366
Rossini M, Zanotti R, Bonadonna P et al (2011) Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone 49(4):880–885
pubmed: 21782049
Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1148
pubmed: 8237484
van der Veer E, van der Goot W, de Monchy JG, Kluin-Nelemans HC, van Doormaal JJ (2012) High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis. Allergy 67(3):431–438
pubmed: 22229787
Frenzel L, Suarez F, Chandesris MO, Hermine O (2012) Ivory vertebra and systemic mastocytosis. Jt Bone Spine 79(3):319–321
Chehab M, Copelan A, Al-faham Z, Bahoura L, Wong CY (2015) Systemic mastocytosis: a rare cause of single vertebral body uptake on bone scan. J Radiol Case Rep 9(2):31–41
pubmed: 25926926
pmcid: 4391801
Graves L 3rd, Stechschulte DJ, Morris DC, Lukert BP (1990) Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes. J Bone Miner Res 5(11):1113–1119
pubmed: 2270775
Chen CC, Andrich MP, Mican JM, Metcalfe DD (1994) A retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis. J Nucl Med 35(9):1471–1475
Avila NA, Ling A, Metcalfe DD, Worobec AS (1998) Mastocytosis: magnetic resonance imaging patterns of marrow disease. Skeletal Radiol 27(3):119–126
pubmed: 9554001
Barer M, Peterson LF, Dahlin DC, Winkelmann RK, Stewart JR (1968) Mastocytosis with osseous lesions resembling metastatic malignant lesions in bone. J Bone Jt Surg Am 50(1):142–152
Guglielmi G, Muscarella S, Bazzocchi A (2011) Integrated imaging approach to osteoporosis: state-of-the-art review and update. Radiographics 31(5):1343–1364
pubmed: 21918048
Kropil P, Fenk R, Fritz LB et al (2008) Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur Radiol 18:51–58
pubmed: 17924119
Meyer HJ, Pönisch W, Monecke A, Gundermann P, Surov A (2020) Can diagnostic low-dose whole-body CT reflect bone marrow findings in systemic mastocytosis? Anticancer Res 40(2):1015–1022
pubmed: 32014947
Haney K, Russell W, Raila FA, Brower AC, Harrison RB (1996) MRI characteristics of systemic mastocytosis of the lumbosacral spine. Skeletal Radiol 25:171–173
pubmed: 8848749
Roca M, Mota J, Giraldo P, García Erce JA (1999) Systemic mastocytosis: MRI of bone marrow involvement. Eur Radiol 9(6):1094–1097
Swartz PG, Roberts CC (2009) Radiological reasoning: bone marrow changes on MRI. AJR Am J Roentgenol 193(3 Suppl):S1-4
pubmed: 19696238
Daldrup-Link HE, Henning T, Link TM (2007) MR imaging of therapy-induced changes of bone marrow. Eur Radiol 17(3):743–761
pubmed: 17021706
Dreizin D, Ahlawat S, Del Grande F, Fayad LM (2014) Gradient-echo in-phase and opposed-phase chemical shift imaging: role in evaluating bone marrow. Clin Radiol 69:648–657
pubmed: 24613580
Del Grande F, Farahani SJ, Carrino JA, Chhabra A (2014) Bone marrow lesions: a systematic diagnostic approach. Indian J Radiol Imaging 24(3):279–287
pubmed: 25114392
pmcid: 4126144
Wasser K, Moehler T, Nosas-Garcia S et al (2005) Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma. Rofo 177:1116–1122
pubmed: 16021544
Vande Berg BC, Lecouvet FE, Galant C, Simoni P, Malghem J (2009) Normal variants of the bone marrow at MR imaging of the spine. Semin Musculoskelet Radiol 13:87–96
pubmed: 19455471
Baur A, Stäbler A, Bartl R, Lamerz R, Scheidler J, Reiser M (1997) MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration. Skelet Radiol 26(7):414–418
Morone M, Bali MA, Tunariu N et al (2017) Whole-body MRI: current applications in oncology. AJR Am J Roentgenol 209(6):W336–W349
pubmed: 28981354
Lecouvet FE (2016) Whole-body MR Imaging: musculoskeletal applications. Radiology 279(2):345–365
pubmed: 27089188
Riffel P, Jawhar M, Gawlik K et al (2019) Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosis. Ann Hematol 98(12):2693–2701
pubmed: 31686155
Padhani AR, Koh DM, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261(3):700–718
pubmed: 22095994
Arrington ER, Eisenberg B, Hartshorne MF, Vela S, Dorin RI (1989) Nuclear medicine imaging of systemic mastocytosis. J Nucl Med 30(12):2046–2048
pubmed: 2585108
Zettinig G, Becherer A, Szabo M et al (2002) FDG positron emission tomography in patients with systemic mastocytosis. AJR Am J Roentgenol 179(5):1235–1237
pubmed: 12388504
Djelbani-Ahmed S, Chandesris MO, Mekinian A et al (2015) FDG-PET/CT findings in systemic mastocytosis: a French multicentre study. Eur J Nucl Med Mol Imaging 42(13):2013–2020
pubmed: 26140850
Rossignol J, Polivka L, Maouche-Chrétien L, et al (2019) Recent advances in the understanding and therapeutic management of mastocytosis. F1000Res 22;8:F1000 Faculty Rev-1961